Medico Remedies Intrinsic Value
Medico Remedies intrinsic value. Medico Remedies (MEDICO) median intrinsic value is ₹41.35 from 9 valuation models (range ₹25–₹55), vs current price ₹22.17 — +86.5% upside (Trading Below Calculated Value), margin of safety 46.4%. For current market price and key ratios, visit Medico Remedies share price screener.
MEDICO Valuation Methods Summary — DCF, Graham Number & P/E
Medico Remedies intrinsic value across 9 models vs current price ₹22.17 — upside/downside and value range per method. Compare with MEDICO fundamental valuation to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹37.40 | ₹29.92 - ₹44.88 | +68.7% | EPS: ₹1.70, Sector P/E: 22x |
| Book Value Method | asset | ₹55.43 | ₹49.89 - ₹60.97 | +150.0% | Book Value/Share: ₹44.71, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹44.34 | ₹39.91 - ₹48.77 | +100.0% | Revenue/Share: ₹143.53, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹44.34 | ₹39.91 - ₹48.77 | +100.0% | EBITDA: ₹24.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹32.77 | ₹26.22 - ₹39.32 | +47.8% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹24.79 | ₹22.31 - ₹27.27 | +11.8% | EPS Growth: 18.2%, Fair P/E: 14.6x |
| Growth Adjusted P/E | growth | ₹27.30 | ₹24.57 - ₹30.03 | +23.1% | Revenue Growth: 14.1%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹44.34 | ₹39.91 - ₹48.77 | +100.0% | ROE: 18.4%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹41.35 | ₹37.22 - ₹45.49 | +86.5% | EPS: ₹1.70, BVPS: ₹44.71 |
MEDICO Intrinsic Value vs Market Price — All Valuation Models
Medico Remedies fair value range ₹25–₹55 vs current market price ₹22.17 across 9 valuation models. Read MEDICO dividend yield for the complete payout history and dividend yield track record.
MEDICO Intrinsic Value Analysis — Undervalued or Overvalued?
Medico Remedies median intrinsic value ₹41.35, current price ₹22.17 — Trading Below Calculated Value by 86.5%, margin of safety 46.4%.
What is the intrinsic value of MEDICO?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Medico Remedies (MEDICO) is ₹41.35 (median value). With the current market price of ₹22.17, this represents a +86.5% variance from our estimated fair value.
The valuation range spans from ₹24.79 to ₹55.43, indicating ₹24.79 - ₹55.43.
Is MEDICO undervalued or overvalued?
Based on our multi-method analysis, Medico Remedies (MEDICO) appears to be trading below calculated value by approximately 86.5%.
MEDICO Financial Health — Key Ratios vs Industry Benchmarks
Medico Remedies financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 18.4% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 8.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.59x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
MEDICO Cash Flow Quality — Operating & Free Cash Flow
Medico Remedies operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹6 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹5 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹8 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹6 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |